244
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Adherence to Option B+ Care for the Prevention of Mother-to-Child Transmission Among Pregnant Women in Ethiopia

, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 769-778 | Published online: 19 Nov 2020

References

  • World Health Organization. Global Guidance on Criteria and Processes for Validation: Elimination of Mother-To-Child Transmission of HIV and Syphilis; 2017.
  • Luzuriaga K, Mofenson LM, Campion EW. Challenges in the elimination of pediatric HIV-1 infection. N Engl J Med. 2016;374(8):761–770. doi:10.1056/NEJMra150525626933850
  • HIV/AIDS JUNPo. UNAIDS Data 2017. Geneva: Joint United Nations Programme on HIV. AIDS; 2017.
  • World Health Organization. Mother-To-Child Transmission of HIV; 2018.
  • Tubiana R, Le Chenadec J, Rouzioux C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/mL at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50(4):585–596.20070234
  • Vrazo AC, Sullivan D, Ryan Phelps B. Eliminating mother-to-child transmission of HIV by 2030: 5 strategies to ensure continued progress. Glob J Health Sci. 2018;6(2):249–256. doi:10.9745/GHSP-D-17-00097
  • Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi:10.7326/0003-4819-133-1-200007040-0000410877736
  • World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016.
  • Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039–2052. doi:10.1097/QAD.0b013e328359590f22951634
  • Awittor RJE. Adherence to Antiretroviral Therapy (ART) Among HIV Positive Women at Antiretroviral Centers in Tema. University of Ghana; 2012.
  • Sabate E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2016.
  • Ethiopian Federal Minstry of Health. National Consolidated Guidelines for Comprehensive Hiv Prevention, Care and Treatment; 8, 2018:2018.
  • Ebuy H, Yebyo H, Alemayehu M. Level of adherence and predictors of adherence to the option B+ PMTCT program in Tigray, northern Ethiopia. Int J Infect Dis. 2015;33:123–129. doi:10.1016/j.ijid.2014.12.02625529555
  • Lodebo TM, Suloro JA. Level of adherence and associated factors to option B+ PMTCT among HIV positive pregnant women in Hadiya Zone, Southern Ethiopia. Glob J Health Sci. 2017;2(1):39–58.
  • Tsegaye D, Deribe L, Wodajo S. Levels of adherence and factors associated with adherence to option B+ prevention of mother-to-child transmission among pregnant and lactating mothers in selected government health facilities of South Wollo Zone, Amhara Region, northeast Ethiopia, 2016. Epidemiol Health. 2016;38:e2016043. doi:10.4178/epih.e201604327733034
  • Tesfaye DJ, Hibistu DT, Abebo TA, et al. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia. BMC Pregnancy Childbirth. 2019;19(1):82. doi:10.1186/s12884-019-2228-430819147
  • Steel G, Nwokike J, Joshi M. Development of a Multi-Method Tool to Measure ART Adherence in Resource-Constrained Settings: The South Africa Experience. Submitted to the U.S. Agency for International Development by the Rational Pharmaceutical Management Plus Program. Arlington, VA: Management Sciences for Health; 2007.
  • Belayihun B, Negus R. Antiretroviral Treatment Adherence Rate and Associated Factors among People Living with HIV in Dubti Hospital, Afar Regional State, East Ethiopia. International Scholarly Research Notices. 2015. doi:10.1155/2015/187360
  • Benta Akoth M, Masaba RO, Fowler MG, et al. CD4, viral load response, and adherence among antiretroviral-naive breastfeeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya. J Acquir Immune Defic Syndr. 2012;61(2):249–257. doi:10.1097/QAI.0b013e318262514f22692094
  • Joseph A, Ogah OE, Robinson O, et al. Determinants of adherence to antiretroviral therapy among HIV-positive women accessing prevention of mother to child transmission services in Ebonyi State, Nigeria. Ann Med Health Sci Res. 2018;8(4).
  • Ng’ambi W, Tweya H, Speight C, et al. Determinants of antiretroviral treatment adherence among women accessing PMTCT “Option B+”: a retrospective study at Bwaila Hospital, Malawi. IAS Conference on HIV pathogenesis, treatment, and prevention; 2013
  • Gugsa S, Potter K, Tweya H, et al. Exploring factors associated with ART adherence and retention in care under Option B+ strategy in Malawi: a qualitative study. PLoS One. 2017;12(6):e0179838. doi:10.1371/journal.pone.017983828636669
  • Haas AD, Msukwa MT, Egger M, et al. Adherence to antiretroviral therapy during and after pregnancy: a cohort study on women receiving care in Malawi’s Option B+ program. Clin Infect Dis. 2016;63(9):1227–1235.27461920
  • Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (“Option B+”) in Malawi. AIDS. 2014;28(4):589. doi:10.1097/QAD.000000000000014324468999
  • Buregyeya E, Naigino R, Mukose A, et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017;17(1). doi:10.1186/s12884-017-1276-x
  • Lumbantoruan C, Kermode M, Giyai A, et al. Understanding women’s uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: a qualitative study. PLoS One. 2018;13(6):e0198329. doi:10.1371/journal.pone.019832929912960
  • Hodgson I, Plummer ML, Konopka SN, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS One. 2014;9(11):e111421. doi:10.1371/journal.pone.011142125372479
  • Cornelius LJ, Erekaha SC, Okundaye JN, et al. A socio-ecological examination of treatment access, uptake and adherence issues encountered by HIV-positive women in Rural North-Central Nigeria. J Evid Inf Soc Work. 2018;15(1):38–51. doi:10.1080/23761407.2017.139758029236624
  • Atanga PN, Ndetan HT, Achidi EA, et al. Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of cameroonian pregnant and breastfeeding HIV-positive women initiating ‘Option B+’ in the South West Region. Trop Med Int Health. 2017;22(2):161–170. doi:10.1111/tmi.1281627865052
  • Omonaiye O, Kusljic S, Nicholson P, Manias E. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review. BMC Public Health. 2018;18(1). doi:10.1186/s12889-018-5651-y
  • Boateng D, Kwapong GD, Agyei-Baffour P. Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study. BMC Womens Health. 2013;13(1). doi:10.1186/1472-6874-13-2
  • Kohler PK, Ondenge K, Mills LA, et al. Shame, guilt, and stress: community perceptions of barriers to engaging in Prevention of Mother to Child Transmission (PMTCT) programs in Western Kenya. AIDS Patient Care STDS. 2014;28(12):643–651. doi:10.1089/apc.2014.017125361205
  • Clouse K, Schwartz S, Van Rie A, et al. “What they wanted was to give birth; nothing else”: barriers to retention in Option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr. 2014;67(1):e12–e18. doi:10.1097/QAI.000000000000026324977376